Zaoutis T, Moore LS, Furness K, Klein JD: In vitro activities of linezolid, meropenem, and quinupristin-dalfopristin against group C and G streptococci, including vancomycin-tolerant isolates. [Antimicrob Agents Chemother] 45: 1952-54, Jun 1905
Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Bilker WB, Lautenbach E: Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection. [Arch Intern Med] 165(12): 1375-80, Jun 2005
Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Fishman NO, Bilker WB, Mao X, Lautenbach E: Risk factors for increasing multi-drug resistance among extended spectrum beta-lactamase-producing Escherichia coli and Klebsiella species. [Clin Infect Dis] 40: 1317-24, May 2005
Bair-Merritt MH, Shah SS, Zaoutis TE, Bell LM, Fuedtner C: Suppurative intracranial complications of sinusitis in previously healthy children. [Pediatr Infect Dis J] 24(4): 384-386, Apr 2005
Σελίδα
70
| 74